What is the NCCN's role in Vietnam's cancer treatment?

The NCCN is collaborating with the Vietnam National Cancer Hospital to adapt its clinical practice guidelines for oncology, aiming to improve cancer treatment standards in Vietnam.

Which cancer guidelines have been adapted for Vietnam?

Adapted guidelines for breast and ovarian cancers have been published, following previous adaptations for lung and liver cancers, with more on the way.

How do the adapted NCCN guidelines benefit cancer patients in Vietnam?

These guidelines customize international standards to Vietnam's practice patterns and healthcare technologies, enhancing the quality of diagnosis and treatment for patients.

Home / Health / US Cancer Guidelines Now Aid Vietnam

US Cancer Guidelines Now Aid Vietnam

2 Feb

•

Summary

Vietnam National Cancer Hospital partners with NCCN for cancer guidelines.
New breast and ovarian cancer guidelines adapted for Vietnamese patients.
This collaboration enhances cancer treatment quality and global standards.

The National Comprehensive Cancer Network (NCCN) is partnering with the Vietnam National Cancer Hospital (K Hospital) to improve cancer treatment across Vietnam. They have published adapted NCCN Clinical Practice Guidelines in Oncology for breast and ovarian cancers, addressing high-incidence cancers for women in the region. These adaptations customize international standards for Vietnam's specific practice patterns and healthcare technologies.

This collaboration signifies a commitment to enhancing cancer care quality and harmonizing treatment with global evidence-based practices. Prof. Le Van Quang highlighted the profound significance of this joint effort, aiming to elevate diagnostic and treatment standards. This follows a 2023 pilot program that adapted guidelines for lung cancer, with liver cancer also adapted, bringing the total to four.

Local panel members contributed essential insights, including management of ovarian cancer during pregnancy. Dr. Quang noted this specific addition provides crucial guidance for complex decision-making in such cases. NCCN CEO Crystal S. Denlinger acknowledged the mutual benefit of this knowledge exchange, which supports research and education worldwide and can inform National Cancer Control Plans.